Catalase

Catalase

1. Identity and Chemical Classification

Nomenclature

Catalase is classified under the Enzyme Commission number EC 1.11.1.6 and belongs to the oxidoreductase superfamily. Its systematic name is hydrogen-peroxide:hydrogen-peroxide oxidoreductase. The gene encoding human catalase is designated CAT, located on chromosome 11p13. Within dietary supplement labeling, the NIH Dietary Supplement Label Database records it under the terms Catalase, Catalase active base, and Catalase complex, and classifies it in the category "Enzyme." The NIH Office of Dietary Supplements Dietary Supplement Label Database categorizes catalase as an enzyme, with related label terms including "Catalase," "Catalase, active base," and "Catalase complex."

Molecular Structure

The functional catalase enzyme exhibits a complex quaternary structure, existing as a homo-tetramer composed of four identical polypeptide subunits arranged in a compact, three-dimensional form; the enzyme's molecular weight typically ranges between 220,000 and 350,000 kilodaltons, reflecting this multi-subunit composition. Catalase is a tetramer of four polypeptide chains, each over 500 amino acids long. Typical catalases are structurally complex homo-tetrameric enzymes with one heme prosthetic group buried in each subunit.

Embedded deep within the core of each subunit is the prosthetic heme group, which is an iron-containing molecule. This heme group serves as the enzyme's catalytic center, where the chemical reaction takes place. The iron atom within the heme is coordinated by several surrounding amino acids, creating the specific chemical environment necessary for function. The active center consists of a heme with a tyrosine ligand on the proximal side and a conserved histidine and an aspartate on the distal side. The active site, where the substrate binds, is accessed through a narrow, funnel-shaped channel approximately 30 Angstroms long; specific amino acid residues, such as histidine and asparagine, line the channel and the active site, directing the substrate and initiating the reaction.

Three distinct classes of catalase are recognized. The first and most widespread class encompasses the monofunctional heme-catalases (typical catalases), the group to which mammalian and most commercially relevant catalases belong. The second class is the bifunctional catalase-peroxidase, which is relatively less abundant in nature and also contains a heme group; it is closely related to plant peroxidases with structural and sequence similarities. The third class belongs to the manganese-containing catalase group, which lacks the heme group. Manganese catalases contain a binuclear manganese complex as their catalytic active site rather than a heme, and cycle between Mn₂(II,II) and Mn₂(III,III) states during turnover.

Natural Sources

Catalase is a common enzyme found in nearly all living organisms exposed to oxygen — such as bacteria, plants, and animals — and catalyzes the decomposition of hydrogen peroxide to water and oxygen. It is found in nearly all oxygen-using organisms and is especially abundant in the liver; within cells, it is located in peroxisomes, where it helps manage reactive oxygen species, protecting DNA, proteins, and cell membranes from oxidative damage.

Among plant species, catalase is found in various plant species such as tobacco, Arabidopsis thaliana, pepper, mustard, saffron, maize, castor bean, sunflower, cotton, wheat, and spinach. Commercially, catalase is produced mainly by extraction from bovine liver and, in more recent years, from the fungi Aspergillus niger and the bacterium Micrococcus luteus; sweet potatoes are also a good source of catalase.

Common Supplement Forms and Preparations

Catalase-only supplement products come in various forms including capsules, liquids, and powder; more commonly, the enzyme is combined with other enzymes, nutrients, or herbs depending on the intended health benefit. Many supplements advertised for reversing hair greying combine catalase with horsetail, saw palmetto, biotin, or folic acid; in other cases, catalase is combined with digestive enzymes and/or probiotics, with the stated aim of supporting gut health; products claiming to offer protection against free radicals combine catalase with vitamins, minerals, or plant-based antioxidants.

Enzyme activity in commercial catalase preparations is commonly expressed in international units (IU) or Baker Units (BU). One Baker Unit is defined as the amount of enzyme that will decompose 264 mg of H₂O₂ in one hour at 25°C and pH 7.0. Industrial and food-grade catalase derived from Aspergillus niger has long been available under standardized preparations, with activity measured in Baker Units and maximum stability typically maintained at refrigerated temperatures.

---

2. Historical and Scientific Discovery

The story of catalase discovery begins with the identification of its substrate. Thénard (1811), the discoverer of hydrogen peroxide, expected that its degradation in living tissue was performed by a special substance, which Schönbein (1863) identified as a certain kind of "ferment." The term "catalase" was formally coined in 1900 by Oscar Loew, a German-American agricultural chemist, during his investigations of plant extracts; Loew identified the activity as a distinct enzyme capable of rapidly decomposing hydrogen peroxide into water and oxygen, present across a wide range of organisms from bacteria to higher plants and animals, and his seminal paper established catalase as a specific enzymatic entity, separate from peroxidases.

It took a further 22 years until Warburg (1923) demonstrated that the active center of catalase contains iron, as concluded from the characteristic inhibition with cyanide. Stern (1936) demonstrated that in all then-known catalases, protoporphyrin IX was the active group, and the first crystals of beef liver catalase were obtained a year later by Sumner and Dounce in 1937. The amino acid sequence of bovine catalase was determined in 1969, and the three-dimensional structure was solved in 1981.

In 1984, Kirkman and Gaetani reported tightly bound NADPH in beef liver catalase, which was then also detected in the X-ray structure of the enzyme. Crystallization work on catalase contributed directly to Nobel Prize recognition: Sumner's work on catalase crystallization, alongside his earlier success with urease, contributed to his sharing the 1946 Nobel Prize in Chemistry for establishing the protein nature of enzymes through crystallization.

Traditional Use

Catalase, as a discrete purified ingredient, has no documented history of traditional use in herbalism or folk medicine. Unlike plant-derived phytochemicals, catalase is an endogenous enzyme; it was not identified as a specific molecular entity until 1900, and it was not isolable in pure form until 1937. Foods naturally rich in catalase activity — such as liver, certain root vegetables, and leafy greens — have long been part of nutritional traditions across cultures, but these were consumed for general nourishment rather than with knowledge of catalase content specifically. The modern history of catalase as a deliberately administered supplement dates to the late 20th and early 21st century, driven by advances in protein biochemistry and the commercial enzyme industry.

---

3. Key Biochemical Constituents and Mechanisms of Action

The Primary Catalatic Reaction

Catalase is a very important enzyme in protecting the cell from oxidative damage by reactive oxygen species (ROS); it has one of the highest turnover numbers of all enzymes — one catalase molecule can convert millions of hydrogen peroxide molecules to water and oxygen each second. The overall stoichiometry of the catalatic reaction is: 2 H₂O₂ → 2 H₂O + O₂. This catalytic reaction occurs in two distinct stages. The first stage involves oxidation of the heme using the first hydrogen peroxide molecule to form an oxyferryl species in which one oxidation equivalent is taken from the iron and one from the porphyrin ring to make a porphyrin cation radical. In the second stage, a second hydrogen peroxide molecule acts as a reductant, restoring the enzyme to its resting ferric state and liberating water and molecular oxygen.

In contrast to the nearly diffusion-controlled turnover rate that is characteristic of heme-containing catalases (k_cat = 4×10⁷ s⁻¹), non-heme manganese catalases exhibit much slower kinetics.

The Peroxidatic Reaction

In addition to the catalatic reaction, catalase can promote the interaction of hydrogen peroxide with compounds that can serve as hydrogen donors so that hydrogen peroxide is converted to one molecule of water while the reduced donor becomes oxidized — a process called the peroxidatic activity of catalase; compounds that can provide these hydrogen atoms include beverage alcohol (ethanol) and methanol. When H₂O₂ concentrations are higher, catalase preferentially performs the "catalatic" reaction to decompose H₂O₂; only at lower H₂O₂ concentrations is the "peroxidatic" reaction — oxidation of ethanol — initiated.

Alongside its protective properties, catalase also mobilizes hydrogen peroxide to neutralize harmful toxins that enter the body, such as methanol, ethanol, and formaldehyde.

Subcellular Localization

Catalases are heme-containing tetrameric enzymes found in subcellular organelles (peroxisomes), the primary source of H₂O₂ production during oxidative stress conditions via photorespiratory oxidation, beta-oxidation of fatty acids, and purine catabolism.

NADPH Binding

Mammalian catalases contain tightly bound NADPH (nicotinamide adenine dinucleotide phosphate). This cofactor is not required for the primary catalatic or peroxidatic activity but is thought to play a protective role by helping prevent enzyme inactivation by hydrogen peroxide at high concentrations. Kirkman and Gaetani (1984) reported tightly bound NADPH in beef liver catalase, which was then also detected in the X-ray structure.

Relationship With the Broader Antioxidant Defense System

Catalase does not function in isolation. Superoxide dismutase (SOD) dismutates superoxide into hydrogen peroxide, which is in turn degraded by catalase or by glutathione peroxidase. Living organisms have sophisticated and efficient antioxidant defense systems against ROS, especially antioxidant enzymes including catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPX). This enzymatic cascade means that catalase's function is deeply integrated with other antioxidant proteins, and perturbations in one component affect the activity of others.

Sensitivity to Environmental Conditions

Changes to the enzyme's shape — caused by factors such as temperature, pH, or mutation — can alter or reduce its activity by disrupting the active site. Catalase is highly sensitive to temperature and undergoes denaturation above 60°C. The rate of reaction also depends on the concentrations of both the enzyme and its substrate, hydrogen peroxide, with reaction rate increasing until the enzyme becomes saturated; additionally, certain chemicals can inhibit catalase activity.

---

4. Scientific Evidence by Area of Use

4.1 Oxidative Stress and Cellular Protection

The foundational role of catalase in oxidative stress biology is robustly established at the biochemical and cellular levels. Reactive species produced in the cell during normal cellular metabolism can chemically react with cellular biomolecules such as nucleic acids, proteins, and lipids, causing oxidative modifications; cells have evolved several antioxidant defense mechanisms to neutralize these harmful effects; any perturbation in the balance between antioxidants and reactive species results in the physiological condition called "oxidative stress," and catalase is one of the crucial antioxidant enzymes that mitigates this condition to a considerable extent by destroying cellular hydrogen peroxide.

Evidence strength: The biochemical role is extremely well established across decades of research. However, clinical evidence that orally administered supplemental catalase increases catalase activity in human tissues remains absent from peer-reviewed literature.

4.2 Aging and Age-Associated Degenerative Disease

Deficiency or malfunction of catalase is postulated to be related to the pathogenesis of many age-associated degenerative diseases, including diabetes mellitus, hypertension, anemia, vitiligo, Alzheimer's disease, Parkinson's disease, bipolar disorder, cancer, and schizophrenia. Degenerative diseases in which the function and structure of tissue or organs deteriorate over time — such as Alzheimer's disease, Parkinson's disease, diabetes, cataracts, cancer, and cardiovascular disease — have been attributed to oxidative stress conditions and the process of natural aging; thus, oxidative stress, aging, and degenerative diseases are interconnected.

Research has explored strategies to harness catalase's anti-aging potential. By mitigating oxidative damage to cellular macromolecules and preserving mitochondrial function, catalase preserves cellular homeostasis and delays the onset of age-related decline; moreover, catalase's involvement in signaling pathways regulating cellular senescence and apoptosis influences the aging process at the molecular level.

Evidence strength: The association between low catalase activity and aging-related disease is supported by extensive observational, genetic, and in vitro data. Human interventional trials using oral catalase supplementation for aging endpoints are, as of current literature, lacking. Most mechanistic evidence derives from animal models and cell-culture experiments.

4.3 Acatalasemia and Inherited Catalase Deficiency

Acatalasemia is a rare, inherited condition caused by loss-of-function mutations in the CAT gene. If hydrogen peroxide is not broken down by catalase, additional reactions convert it into compounds called reactive oxygen species that can damage DNA, proteins, and cell membranes; mutations in the CAT gene greatly reduce catalase activity; a shortage of this enzyme can allow hydrogen peroxide to build up to toxic levels in certain cells; for example, hydrogen peroxide produced by bacteria in the mouth may accumulate in and damage soft tissues, leading to mouth ulcers and gangrene.

Catalase gene mutations have been detected in association with diabetes mellitus, hypertension, and vitiligo; acatalasemia — the inherited deficiency of catalase — has been detected in 11 countries; its clinical features may include oral gangrene, altered lipid, carbohydrate, and homocysteine metabolism, and an increased risk of diabetes mellitus. The condition is estimated to occur in approximately 1 in 12,500 people in Japan, 1 in 20,000 people in Hungary, and 1 in 25,000 people in Switzerland. Many individuals with this condition show no symptoms and are never diagnosed except through affected family members.

Human inherited or acquired catalase deficiency may predispose to methemoglobinemia and hemolysis in patients receiving uric acid oxidase (rasburicase) therapy, and most (85.1%) have one of the more common age-related chronic disorders such as senile graying of hair, diabetes mellitus, oral gangrene, schizophrenia, vitiligo, Parkinson's disease, arteriosclerosis, and hypertension.

Evidence strength: The clinical phenotype of acatalasemia is well described in case series and epidemiological data; the genetic basis is established. There are no controlled trials of catalase supplementation as a treatment for acatalasemia in humans.

4.4 Vitiligo

Vitiligo is among the most-studied clinical conditions with respect to catalase. Patients with vitiligo have low catalase levels in their involved and uninvolved epidermis, in association with high levels of hydrogen peroxide (H₂O₂); H₂O₂ was confirmed for the first time in vivo using Fourier Transform Raman spectroscopy; a topical substitution with a UVB-activated pseudocatalase can successfully remove epidermal H₂O₂ in vitiligo; this approach leads to recovery of the oxidative damage in the epidermis and remarkable repigmentation in this disorder.

High levels of H₂O₂ in the epidermis are toxic for melanocytes, inhibit tyrosinase, and also deactivate catalase, which is a peroxisomal enzyme catalyzing the reduction of H₂O₂ to water and oxygen; such imbalance between oxidative damage and antioxidant enzyme systems plays an important role in melanocyte destruction.

Pseudocatalase (PC-KUS), a synthetic manganese complex that mimics catalase's function and is activated by ultraviolet B radiation, has been the main investigational approach. Pseudocatalase is a bis-manganese III-EDTA-(HCO₃⁻)₂ complex activated by UVB or natural sun; this complex was used in a pilot study on 33 patients, showing remarkable repigmentation even in long-lasting disease. The most extensive patient cohort treated with this approach was documented by Schallreuter et al., whose study enrolled 71 patients presenting with generalized vitiligo, categorized into a control group of 10 patients receiving NB-UVB radiation and 61 individuals also receiving daily topical application of pseudocatalase.

However, results have been mixed. Many studies have been conducted to show the usefulness of this regimen, although some have failed to show such results. In a study by Khemis et al., 30 patients with bilateral lesions used pseudocatalase plus UVB on one lesion and placebo plus UVB on the other; the result showed no significant difference between control and treated lesions.

Evidence strength: Preliminary and mixed. The mechanistic basis — epidermal H₂O₂ accumulation and reduced catalase — is well-documented. Pseudocatalase is not true catalase protein but a synthetic manganese mimetic. Results from clinical trials are inconsistent, and there are no large randomized controlled trials (RCTs) confirming efficacy of pseudocatalase or native catalase supplementation in vitiligo.

4.5 Hair Graying

One of the most commercially prominent applications of catalase supplements relates to hair greying. It is believed that a decline in catalase activity allows hydrogen peroxide to accumulate in hair follicles, leading to the bleaching effect that results in gray hair. Low levels of this enzyme have been associated with the graying of hair, indicating its significance in cellular health.

While the idea of reversing gray hair with catalase supplements is tempting, the current scientific evidence does not support it. No published, peer-reviewed human clinical trial has demonstrated that orally administered catalase supplements reverse or prevent hair graying in humans.

Evidence strength: The biochemical hypothesis is plausible and mechanistically coherent. However, it is unvalidated by human clinical trials. The association is currently at the level of observational and in vitro data only.

4.6 Cardiovascular Disease

Catalase, abundant within cardiac tissue, stands as a frontline defender against oxidative insult, safeguarding cardiomyocytes from ROS-induced damage; in conditions such as ischemia-reperfusion injury — characterized by transient oxygen deprivation followed by reoxygenation — catalase's enzymatic activity is instrumental in attenuating oxidative stress-mediated myocardial injury; by neutralizing hydrogen peroxide, catalase preserves myocardial contractility and mitigates inflammation, thereby reducing the extent of ischemic damage.

Clinical trials evaluating the safety and efficacy of catalase-based therapies in oxidative stress-related diseases, including cardiovascular disorders, neurodegenerative diseases, and diabetes mellitus, are underway.

Evidence strength: Largely preclinical (animal models and in vitro). The mechanistic rationale is strong, but human trial data on supplemental catalase for cardiovascular outcomes are not yet available in the published literature.

4.7 Diabetes Mellitus

Hydrogen peroxide at high concentrations is a toxic agent, while at low concentrations it appears to modulate some physiological processes such as signaling in cell proliferation, apoptosis, carbohydrate metabolism, and platelet activation. Catalase is directly implicated in pancreatic beta-cell protection: the build-up of hydrogen peroxide causes damage to beta cells of the pancreas, which release insulin to control blood sugar levels; this is why individuals with acatalasemia are at risk for type 2 diabetes. Certain polymorphisms in the catalase gene have been described in association with diabetes, hypertension, vitiligo, Alzheimer's disease, and acatalasemia, leading to decreased catalase activities.

Evidence strength: Genetic epidemiology and in vitro data support a mechanistic link between low catalase and impaired beta-cell function. Clinical intervention trials using catalase supplementation in diabetes are not available in the peer-reviewed literature.

4.8 Cancer Biology

Catalase is frequently downregulated in human and rodent tumor tissues compared to normal tissues of the same origin. Catalase is a key enzyme in the metabolism of H₂O₂ and reactive nitrogen species, and its expression and localization are markedly altered in tumors. CAT plays a crucial role due to pathological events connected to its dysfunction, such as increased vulnerability to apoptosis, tumor stimulation, regulated aging, and inflammation.

Research has also explored the opposite approach — catalase inhibition as an anticancer strategy. Catalase is an important antioxidant enzyme that breaks down H₂O₂ into water and oxygen; inhibitor-modulating CAT activity in cancer cells is emerging as a potential anticancer strategy. An NADPH-binding site inhibitor of catalase was demonstrated to induce ferroptosis in castration-resistant prostate cancer (CRPC) cells and to reduce CRPC tumors in vivo effectively.

Evidence strength: Preclinical only. The relationship between catalase and cancer is complex and bidirectional — upregulation of catalase may protect normal cells, while inhibition of tumor-cell catalase may sensitize cancer cells to oxidative killing. No human trials of catalase as a cancer therapeutic supplement are available in the peer-reviewed literature.

4.9 Gastrointestinal Inflammatory Conditions

Research in targeted oral delivery has investigated catalase for inflammatory bowel disease (IBD). Several studies have confirmed a correlation between elevated hydrogen peroxide levels in patients with IBD and the negative effects caused by its presence; the objective of oral catalase delivery research is to diminish H₂O₂ levels and their deleterious action on intestinal mucosa. H₂O₂ was found to contribute to motor dysfunction and to reducing the intracellular Ca²⁺ signal in ulcerative colitis (UC); cytosolic Ca²⁺ levels were investigated before and after the addition of catalase to isolated circular muscle cells, with measurements showing catalase-induced restoration of Ca²⁺ levels.

H₂O₂ is also produced in the gut mucosa; reactive oxygen species including H₂O₂ modulate intestinal epithelial ion transport, contributing to IBD-associated diarrhea.

Evidence strength: Preclinical and mechanistic. No published human clinical trials of oral catalase for IBD outcomes are available. The major research focus is on formulation challenges — how to deliver active catalase to the intestine intact.

4.10 Alcohol Metabolism

The liver metabolizes ethanol through three enzymatic pathways: alcohol dehydrogenase (ADH), cytochrome P450 (MEOS), and catalase; alcohol dehydrogenase class I is considered the most important enzyme for the metabolism of ethanol, while MEOS and catalase are considered minor alternative pathways. Unlike ADH and CYP2E1, catalase oxidizes ethanol without formation of large amounts of NADH (inhibiting fatty acid oxidation) or depletion of NADPH (inducing oxidative stress), making it an apparently innocuous metabolic pathway for alcohol oxidation.

Evidence strength: The role of endogenous catalase in hepatic ethanol metabolism is established biochemically. This is a normal physiological function, not a use case for supplementation.

---

5. Body Systems and Health Areas Associated With Catalase

• Cellular/Peroxisomal Biology: Catalase is a heme-containing tetrameric enzyme found in subcellular organelles (peroxisomes), the primary source of H₂O₂ production during oxidative stress conditions.
• Cardiovascular System: Catalase, abundant within cardiac tissue, stands as a frontline defender against oxidative insult, safeguarding cardiomyocytes from ROS-induced damage.
• Endocrine / Metabolic System: The build-up of hydrogen peroxide causes damage to beta cells of the pancreas, impairing insulin regulation and increasing risk for type 2 diabetes.
• Nervous System: Deficiency or malfunction of catalase is postulated to be related to the pathogenesis of Alzheimer's disease, Parkinson's disease, bipolar disorder, and schizophrenia.
• Integumentary System (Skin and Hair): Patients with vitiligo have low catalase levels in their involved and uninvolved epidermis in association with high levels of H₂O₂. Hair follicle catalase decline is mechanistically associated with graying.
• Hepatic / Detoxification: The liver metabolizes ethanol partly through catalase, as one of three known enzymatic pathways.
• Gastrointestinal System: Reactive oxygen species, including H₂O₂, modulate intestinal epithelial ion transport, contributing to IBD-associated diarrhea.
• Immune System: Living organisms have sophisticated antioxidant defense systems against ROS, in which catalase is one of the key components alongside SOD and glutathione peroxidase.

---

6. Dosage Forms and Reported Dosages

Supplement Forms

Catalase supplement products are available in various forms including capsules, liquids, and powder. Activity is commonly expressed in IU (international units) per serving, with commercially available dietary supplement labels referencing amounts such as 625 IU per serving according to NIH DSLD records. Because catalase is not approved by the FDA for any condition, there is no official dose.

Dosages Reported in Published Research

In animal supplementation studies, dosages are generally expressed in activity units per kilogram of diet rather than per body weight, and these figures are not directly transferable to human supplementation:

• Dietary supplementation with 2,000 mg/kg exogenous CAT (dietary CAT activity, 120 U/kg) has been reported to improve growth performance and enhance antioxidant enzyme activities in weaned piglets.
• In a study of pregnant sows, animals were fed a basal diet supplemented with 660 mg/kg CAT at a catalase activity of 280 U/g.
• In a broiler chicken study, 144 one-day-old birds were divided into groups; the treatment group received a diet with 200 U/kg CAT added.

For topical pseudocatalase in vitiligo, treatment involved a topical application of pseudocatalase and calcium in combination with short-term UVB exposure, as described in a case study on 33 patients. Exact concentration figures for the pseudocatalase cream formulation used clinically (PC-KUS) are not standardly reported in available abstracts.

No peer-reviewed human clinical trials have established a validated effective oral dose of catalase protein for any health outcome. Supplement manufacturers list doses ranging from several hundred to tens of thousands of IU per serving, but these have not been validated in controlled trials.

---

7. Bioavailability and Stability Challenges

A fundamental challenge facing the use of catalase as an oral supplement is protein stability in the gastrointestinal tract. During the manufacturing of biopharmaceuticals, proteins are subjected to different forms of stress — such as agitation, temperature, light exposure, and oxidation — which can lead to protein denaturation; additionally, the physiological conditions of the gastrointestinal tract, specifically the acidic pH and the digestive hydrolases of the gastric environment, can affect the protein structure, often leading to denaturation and activity loss.

Clinical trials with antioxidant enzymes (including catalase) have provided little therapeutic benefit due to the instability of these enzymes in the gastrointestinal tract and nonspecific drug distribution and rapid clearance at diseased sites.

There is no clear evidence that oral supplements significantly increase catalase levels in target tissues; however, delivery methods are under investigation to provide the therapeutic benefit of increased catalase function in certain diseases. Challenges in therapeutic application include stability, bioavailability, and targeted delivery to tissues; advanced formulations and delivery systems are being explored to overcome these hurdles; catalase's therapeutic use faces obstacles including short half-life, poor cellular absorption, and delivery issues; innovations in nanotechnology, gene therapy, and protein engineering may provide answers to enhance its stability, activity, and targeted delivery.

Research into formulation strategies has shown some promise. When compressed as an excipient-free tablet at 100% catalase loading, catalase presents gastric stability with 63% remaining activity inside the tablet, due to possible intra- and inter-chain protein associations generating an outer protective gel layer; however, free catalase in solution is almost totally degraded under the same conditions, illustrating the essential role of formulation. In research using solid lipid microparticles (SLMs) based on glyceryl trimyristate via spray congealing technology, circular dichroism and fluorescence spectroscopies confirmed that no conformational change occurred during the production process and both the secondary and tertiary structures of catalase were retained.

---

8. Safety Considerations and Interactions

General Safety Profile

Catalase is an endogenous enzyme produced by virtually all aerobic organisms, and it is present throughout the food supply. CAT is a widespread enzyme found in nearly all living organisms exposed to oxygen. As a normal constituent of food and of the human body itself, dietary exposure to catalase through food presents no known toxicological concern. The FDA permits the use of catalase in food processing, particularly for its approved role in removing residual hydrogen peroxide from milk, cheese, and other dairy products. The FDA permits the use of H₂O₂ in products such as cheese, milk, eggs, and whey, but stipulates that residual H₂O₂ must be removed from the product; while the FDA does not define a specific method for removal, many regulations dealing with specific products suggest the use of catalase.

Inhibitors of Catalase Activity

Several pharmacological and chemical agents can inhibit catalase activity, which is relevant both to drug interactions and to research:

• 3-Amino-1,2,4-triazole (3-AT): A well-characterized competitive catalase inhibitor used extensively in research. The catalase inhibitor 3-AT completely inhibited catalase-mediated stimulation of ethanol oxidation in experimental settings.
• Cyanide: In the 1920s, Warburg and colleagues demonstrated, using cyanide as an enzyme inhibitor, that the active site of catalase contains an iron atom. Cyanide binds to the heme iron and blocks catalytic activity.
• Azide: Inhibition of microsomal ethanol oxidation by formate, azide, and H₂O₂-utilizing systems is consistent with a peroxidatic process involving catalase. Azide is another heme-directed catalase inhibitor.

Disease-Related Alterations

Catalase itself may be targeted by damaging oxidative stress, leading to decreased enzyme activity and accumulation of hydrogen peroxide. This creates a self-reinforcing cycle in conditions of oxidative stress: elevated H₂O₂ inactivates catalase, further raising H₂O₂ levels.

Pseudocatalase (PC-KUS) Safety Note

The pseudocatalase preparation used in vitiligo research is a manganese-containing complex, not the native protein. Safety considerations relevant to the native enzyme do not automatically transfer to this synthetic mimetic. The manganese content of pseudocatalase cream carries specific considerations — manganese accumulation could potentially lead to complications if used chronically or without monitoring, and patients using it should be assessed and supervised appropriately under clinical guidelines.

Absence of Evidence for Oral Supplement Risks

Because no controlled human trials of oral catalase supplementation have been conducted, formal pharmacovigilance data on adverse effects, contraindications, or drug interactions specific to supplemental catalase are not available in the peer-reviewed literature. The NIH DSLD catalogues catalase under standard dietary supplement categories for enzymes, but no adverse effects have been formally characterized for supplemental oral catalase in humans.

---

9. Industrial and Non-Supplement Applications

For context, catalase has well-documented, regulated applications in industry that further establish its identity:

• Catalase is used in the food industry for removing hydrogen peroxide from milk prior to cheese production, and in food wrappers where it prevents food from oxidizing.
• Catalase is also used in the textile industry to remove hydrogen peroxide from fabrics; a minor use is in contact lens hygiene, where some lens-cleaning products disinfect lenses using a hydrogen peroxide solution, and a catalase solution is then used to decompose the hydrogen peroxide before lens insertion.
• Commercial catalases are also used to break down hydrogen peroxide in wastewater.

---

10. Summary of Evidence Quality

Catalase is among the most extensively studied enzymes in biochemistry. Its endogenous biological functions — particularly the rapid decomposition of cytotoxic hydrogen peroxide — are definitively established across all domains of life. Its association with oxidative stress-related diseases is robustly supported by genetic epidemiology, observational studies, and mechanistic research. However, the use of orally administered catalase as a dietary supplement remains scientifically unvalidated:

• No peer-reviewed human RCTs have demonstrated that oral catalase supplementation increases tissue catalase activity in humans.
• No peer-reviewed human RCTs have demonstrated clinical benefit (for any condition) attributable to oral catalase supplementation.
• The primary technical obstacles — gastrointestinal degradation, poor bioavailability, and lack of targeted tissue delivery — are acknowledged by researchers developing novel formulation strategies, and have not yet been overcome in products available to consumers.
• As with catalase-only supplements, the evidence to support the use of this enzyme in combination with any other substance is completely lacking.

Research into novel delivery systems (nanoparticles, solid lipid microparticles, pH-responsive polymer matrices, and gene therapy) represents the most active frontier for catalase's translational potential.

References

• NIH Office of Dietary Supplements – Dietary Supplement Label Database: Catalase
• Nandi A, et al. (2019). Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases. Oxidative Medicine and Cellular Longevity. PMC6885225
• Therapeutic potentials of catalase: Mechanisms, applications, and future perspectives. PMC10915913
• Effect of Maternal Catalase Supplementation on Reproductive Performance, Antioxidant Activity and Mineral Transport in Sows and Piglets. PMC8996845
• Dietary Catalase Supplementation Alleviates Deoxynivalenol-Induced Oxidative Stress and Gut Microbiota Dysbiosis in Broiler Chickens. PMC9784562
• Design of Catalase Monolithic Tablets for Intestinal Targeted Delivery. PMC7825700
• Solid Lipid Microparticles for Oral Delivery of Catalase: Focus on the Protein Structural Integrity and Gastric Protection. PMC8009523
• The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study. PMC4076862
• In Vitro Assembly of Catalase. PMC4192493
• Monofunctional Heme-Catalases. PMC9687031
• Non-heme Manganese Catalase – the 'Other' Catalase. PMC3328634
• Evolution of Catalases from Bacteria to Humans. PMC2959186
• Plant Catalase in Silico Characterization and Phylogenetic Analysis with Structural Modeling. PMC9391562
• Ethanol Metabolism in the Liver, the Induction of Oxidant Stress, and the Antioxidant Defense System. PMC9312216
• Alcohol, Oxidative Stress, and Free Radical Damage. PMC6668865
• A Catalase Inhibitor: Targeting the NADPH-Binding Site for Castration-Resistant Prostate Cancer Therapy. PMC10213376
• Catalase enzyme mutations and their association with diseases. PubMed 15771551
• Successful treatment of oxidative stress in vitiligo (Schallreuter et al.). PubMed 10393521
• MedlinePlus Genetics: Acatalasemia
• ScienceDirect Topics: Catalase Deficiency
• ScienceDirect Topics: Catalase — Overview
• Typical Catalases: Function and Structure. IntechOpen
• Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach. De Gruyter
• Understanding the structure and function of catalases: clues from molecular evolution and in vitro mutagenesis. ScienceDirect
• EBSCO Research Starters: Catalase
• Wikipedia: Catalase
• StatPearls: Biochemistry, Heme Synthesis. NCBI Bookshelf NBK537329